Swiss National Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-143,200
| Closed | -$21.6M | – | 2795 |
|
|
2022
Q3 | $21.6M | Buy |
143,200
+1,900
| +1% | +$287K | 0.02% | 617 |
|
|
2022
Q2 | $20.6M | Buy |
141,300
+1,900
| +1% | +$277K | 0.01% | 624 |
|
|
2022
Q1 | $16.5M | Buy |
139,400
+9,800
| +8% | +$1.16M | 0.01% | 766 |
|
|
2021
Q4 | $17.9M | Buy |
129,600
+200
| +0.2% | +$27.6K | 0.01% | 726 |
|
|
2021
Q3 | $18M | Buy |
129,400
+10,500
| +9% | +$1.46M | 0.01% | 714 |
|
|
2021
Q2 | $11.5M | Buy |
118,900
+2,400
| +2% | +$233K | 0.01% | 939 |
|
|
2021
Q1 | $7.96M | Buy |
116,500
+1,800
| +2% | +$123K | 0.01% | 1139 |
|
|
2020
Q4 | $9.83M | Buy |
114,700
+1,900
| +2% | +$163K | 0.01% | 942 |
|
|
2020
Q3 | $7.33M | Buy |
112,800
+2,200
| +2% | +$143K | 0.01% | 963 |
|
|
2020
Q2 | $8.09M | Buy |
110,600
+24,600
| +29% | +$1.8M | 0.01% | 878 |
|
|
2020
Q1 | $2.93M | Buy |
86,000
+1,200
| +1% | +$40.8K | ﹤0.01% | 1217 |
|
|
2019
Q4 | $4.62M | Buy |
84,800
+2,600
| +3% | +$142K | ﹤0.01% | 1205 |
|
|
2019
Q3 | $3.43M | Buy |
82,200
+700
| +0.9% | +$29.2K | ﹤0.01% | 1332 |
|
|
2019
Q2 | $3.57M | Buy |
81,500
+44,700
| +121% | +$1.96M | ﹤0.01% | 1326 |
|
|
2019
Q1 | $1.89M | Buy |
36,800
+1,300
| +4% | +$66.9K | ﹤0.01% | 1694 |
|
|
2018
Q4 | $1.31M | Buy |
35,500
+1,600
| +5% | +$59.2K | ﹤0.01% | 1828 |
|
|
2018
Q3 | $1.27M | Buy |
33,900
+2,600
| +8% | +$97.6K | ﹤0.01% | 2006 |
|
|
2018
Q2 | $1.24M | Hold |
31,300
| – | – | ﹤0.01% | 2037 |
|
|
2018
Q1 | $806K | Buy |
31,300
+16,000
| +105% | +$412K | ﹤0.01% | 2197 |
|
|
2017
Q4 | $413K | Buy |
+15,300
| New | +$413K | ﹤0.01% | 2448 |
|